Clinical trials of the world’s first coronavirus vaccine on volunteers have been successfully conducted at Sechenov First Moscow State Medical University, Sputnik News Agency announced quoting an official.
Sechenov First Moscow State Medical University began clinical trials on the vaccine developed by the Russian Gamalei Institute of Epidemiology and Microbiology on 18 June.
According to Alexander Lukashev, director of the Institute of Medical Parasitology, Tropical and Vector-Borne Diseases at the University of Sechenov, the goal of this phase of the research was to demonstrate the efficacy of the vaccine for human health, which has been successfully accomplished.
The safety of the vaccine is confirmed. It corresponds to the safety of those vaccines that are currently on the market, Lukashev told Sputnik.
A further vaccine development program has already been established by the developer’s strategy, considering the uncertainty of the epidemiological situation with the virus and the prospect of scaling up production, Lukashev added.
